Healthcare -
Biotechnology - NASDAQ - US
$ 42.365
-1.29 %
$ 3.92 B
Market Cap
-6.74
P/E
RARE - OTHER LONG-TERM ASSETS
Other Long-term Assets RARE - Ultragenyx Pharmaceutical Inc.
198 M
LAST VALUE
329.77%
2 YEAR CAGR
117.94%
5 YEAR CAGR
38.80%
10 YEAR CAGR